Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
awareness
Marketing
Neurocrine joins in on Tardive Dyskinesia Awareness Week
Neurocrine, maker of the first drug approved by the FDA to treat TD, is throwing its weight behind efforts to improve awareness of the disorder.
Andrea Park
May 6, 2024 10:52am
Medtronic backs push to activate heart valve disease patients
Apr 26, 2024 7:35am
New campaign wants Americans to 'get a pulse on PAD'
Feb 21, 2024 10:55am
Estée Lauder goes all out for Breast Cancer Awareness Month
Oct 2, 2023 9:55am
Novartis shines a light on HS at the Tribeca Festival
Jun 8, 2023 7:50am
Almirall finds 85% of patients are unaware of Klisyri indication
Jun 5, 2023 9:30am